目的:系统评价羟考酮控释片与氨酚羟考酮镇痛效果及安全性差异.方法:采用循证医学的文献分析评价方法,计算机检索Medline、EMBase、Pubmed、Cochrane图书馆临床对照试验资料库、万方数据、中国期刊全文数据库(CNKI),收集奥施康定控释片与氨酚羟考酮疗效及安全性的随机对照研究.评价纳入研究的方法学质量,提取有效数据,采用RevMan5.2软件对数据进行Meta分析.结果:共纳入5篇随机对照试验,Meta分析结果显示:羟考酮缓释片与氨酚羟考酮镇痛效果比较,差异无统计学意义(OR=0.91,95 %CI 0.54~ 1.52,P=0.14),两者的不良反应比较,差异无统计学意义(OR=0.58,95%CI 0.20~1.70,P=0.32).结论:羟考酮缓释片与氨酚羟考酮镇痛效果相当,且两者不良反应相差不大.249-11,封42
OBJECTIVES: This study was designed to evaluate the clinical efficacy of controlled-release morphine...
OBJECTIVES: To assess efficacy and safety of the association oxycodone/acetaminophen (oxycodone/acet...
To investigate the possible role and tolerability of high-dose (>160 mg/day) oxycodone controlled re...
目的:探讨盐酸羟考酮缓释片联合即释吗啡片用于中重度癌痛患者滴定的有效和安全.方法:采用数字分级法对疼痛进行评分,对中重度癌痛患者分别使用盐酸羟考酮缓释片lOmg和20mg,ql2h进行滴定,即释吗啡片...
目的:考察泰勒宁胶囊对术后疼痛及癌症疼痛临床镇痛效果和不良反应.方法:采用多中心随机开放平行对照试验.共完成102例,其中治疗组72例予泰勒宁,单次1粒或每次1粒,tid,疗程1d;对照组30例子泰诺...
目的:探讨阿片类药物滴定法治疗癌痛的疗效及不良反应分析,为临床治疗提供依据.方法:采用回顾性分析选择2012年1月~2015年12月我院收治的肿瘤患者共110例,采用数字评定量表(NRS)和面部表情疼...
Abstract Background Controlled-release oxycodone/naloxone (OXN-CR) maintains the effect of opioid-in...
目的 观察口服氨酚羟考酮片在膝关节置换术后患者中的镇痛疗效和安全性,选择最佳的给药剂量.方法 选择行单侧全膝关节置换患者50例,随机分为氨酚羟考酮10mg组和5mg组,均为Q8H给药,同时使用股神经阻...
BackgroundOxycodone hydrochloride is a semisynthetic narcotic analgesic agent. This study aimed to e...
目的:探讨联合应用长短效吗啡制剂对癌痛患者生活质量的影响.方法:随机将93例中-重度晚期癌痛患者分为3组,分别给予吗啡即释片、吗啡控释片和联合治疗,观察对各种生活质量指标的影响.结果:疼痛控制的有效率...
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
Introduction: Appropriate pain relief enhances patient satisfaction and reduces patient anxiety. Thi...
none17siContext Oxycodone and morphine are recommended as first-choice opioids for moderate/severe c...
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
John Markman,1 Diana S Meske,2 Ernest A Kopecky,2 Ben Vaughn,3 Melinda L O’Connor,2 Steve...
OBJECTIVES: This study was designed to evaluate the clinical efficacy of controlled-release morphine...
OBJECTIVES: To assess efficacy and safety of the association oxycodone/acetaminophen (oxycodone/acet...
To investigate the possible role and tolerability of high-dose (>160 mg/day) oxycodone controlled re...
目的:探讨盐酸羟考酮缓释片联合即释吗啡片用于中重度癌痛患者滴定的有效和安全.方法:采用数字分级法对疼痛进行评分,对中重度癌痛患者分别使用盐酸羟考酮缓释片lOmg和20mg,ql2h进行滴定,即释吗啡片...
目的:考察泰勒宁胶囊对术后疼痛及癌症疼痛临床镇痛效果和不良反应.方法:采用多中心随机开放平行对照试验.共完成102例,其中治疗组72例予泰勒宁,单次1粒或每次1粒,tid,疗程1d;对照组30例子泰诺...
目的:探讨阿片类药物滴定法治疗癌痛的疗效及不良反应分析,为临床治疗提供依据.方法:采用回顾性分析选择2012年1月~2015年12月我院收治的肿瘤患者共110例,采用数字评定量表(NRS)和面部表情疼...
Abstract Background Controlled-release oxycodone/naloxone (OXN-CR) maintains the effect of opioid-in...
目的 观察口服氨酚羟考酮片在膝关节置换术后患者中的镇痛疗效和安全性,选择最佳的给药剂量.方法 选择行单侧全膝关节置换患者50例,随机分为氨酚羟考酮10mg组和5mg组,均为Q8H给药,同时使用股神经阻...
BackgroundOxycodone hydrochloride is a semisynthetic narcotic analgesic agent. This study aimed to e...
目的:探讨联合应用长短效吗啡制剂对癌痛患者生活质量的影响.方法:随机将93例中-重度晚期癌痛患者分为3组,分别给予吗啡即释片、吗啡控释片和联合治疗,观察对各种生活质量指标的影响.结果:疼痛控制的有效率...
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
Introduction: Appropriate pain relief enhances patient satisfaction and reduces patient anxiety. Thi...
none17siContext Oxycodone and morphine are recommended as first-choice opioids for moderate/severe c...
Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can impro...
John Markman,1 Diana S Meske,2 Ernest A Kopecky,2 Ben Vaughn,3 Melinda L O’Connor,2 Steve...
OBJECTIVES: This study was designed to evaluate the clinical efficacy of controlled-release morphine...
OBJECTIVES: To assess efficacy and safety of the association oxycodone/acetaminophen (oxycodone/acet...
To investigate the possible role and tolerability of high-dose (>160 mg/day) oxycodone controlled re...